Orexa Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$691K
- Investors
-
2
Orexa General Information
Description
Developer of commercial therapeutics designed to help increase food intake and improve health. The company's formulation leads to local analgesic action in the stomach and delays the signaling to the brain that the stomach is full, offering a slower onset of satiety, leading to increased food intake and enabling healthcare professionals to prevent post-operative ileus.
Contact Information
Website
www.orexa.euCorporate Office
- Berghemseweg 8
- 5373 KH Herpen
- Netherlands
Corporate Office
- Berghemseweg 8
- 5373 KH Herpen
- Netherlands
Orexa Timeline
Orexa Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC | 20-May-2026 | $691K | Completed | Clinical Trials - Phase 2 | ||
| 6. Later Stage VC | 27-Jan-2025 | Completed | Clinical Trials - Phase 2 | |||
| 5. Later Stage VC | 06-Jun-2024 | Completed | Clinical Trials - Phase 2 | |||
| 4. Later Stage VC | 31-Jan-2024 | Completed | Clinical Trials - Phase 2 | |||
| 3. Later Stage VC | 10-Jan-2023 | Completed | Clinical Trials - Phase 1 | |||
| 2. Later Stage VC | 31-Aug-2022 | $1.21M | $2.12M | Completed | Clinical Trials - Phase 1 | |
| 1. Seed Round | 01-Mar-2022 | $906K | $906K | Completed | Clinical Trials - Phase 1 |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Orexa Patents
Orexa Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2022395186-A1 | Gastro-retentive oral dosage unit containing a local anaesthetic | Pending | 25-Nov-2021 | ||
| CA-3238888-A1 | Gastro-retentive oral dosage unit containing a local anaesthetic | Pending | 25-Nov-2021 | ||
| EP-4436552-A1 | Gastro-retentive oral dosage unit containing a local anaesthetic | Active | 25-Nov-2021 | ||
| EP-4436552-B1 | Gastro-retentive oral dosage unit containing a local anaesthetic | Active | 25-Nov-2021 | ||
| EP-4436552-C0 | Gastro-retentive oral dosage unit containing a local anaesthetic | Active | 25-Nov-2021 | A61K31/167 |
Orexa Signals
Orexa Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Stichting Participatie Atriva | Venture Capital | Minority | ||
| Vectrix (Netherlands) | Venture Capital | Minority |
Orexa FAQs
-
When was Orexa founded?
Orexa was founded in 2016.
-
Where is Orexa headquartered?
Orexa is headquartered in Herpen, Netherlands.
-
What is the size of Orexa?
Orexa has 4 total employees.
-
What industry is Orexa in?
Orexa’s primary industry is Drug Discovery.
-
Is Orexa a private or public company?
Orexa is a Private company.
-
What is the current valuation of Orexa?
The current valuation of Orexa is .
-
What is Orexa’s current revenue?
The current revenue for Orexa is .
-
How much funding has Orexa raised over time?
Orexa has raised $5.3M.
-
Who are Orexa’s investors?
Stichting Participatie Atriva and Vectrix (Netherlands) have invested in Orexa.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process